NCT02319070View on ClinicalTrials.gov

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

January 13, 2015

Primary Completion Date

May 28, 2017

Study Completion Date

February 28, 2018

Conditions
Hemophilia A
Interventions
OTHER

Survey

Recombinant antihemophilic factor VIII (FVIII) on Secondary Prophylaxis treatment scheduled according to daily routine

OTHER

Survey

Recombinant antihemophilic factor VIII (FVIII) On Demand treatment scheduled according to daily routine

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY